Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by <i>KRAS</i> Mutation Subtypes.

Ruppert, Anne-Marie; Beau-Faller, Michèle; Debieuvre, Didier; Ouafik, L'Houcine; Westeel, Virginie; Rouquette, Isabelle; Mazières, Julien; Bringuier, Pierre-Paul; Monnet, Isabelle; Escande, Fabienne; Ricordel, Charles; Merlio, Jean-Philippe; Janicot, Henri; Lemoine, Antoinette; Foucher, Pascal; Poudenx, Michel; Morin, Franck; Langlais, Alexandra; Souquet, Pierre-Jean; Barlesi, Fabrice; Wislez, Marie

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes.

Ruppert, Anne-Marie; Beau-Faller, Michèle; Debieuvre, Didier; Ouafik, L'Houcine; Westeel, Virginie; Rouquette, Isabelle; Mazières, Julien; Bringuier, Pierre-Paul; Monnet, Isabelle; Escande, Fabienne; Ricordel, Charles; Merlio, Jean-Philippe; Janicot, Henri; Lemoine, Antoinette; Foucher, Pascal; Poudenx, Michel; Morin, Franck; Langlais, Alexandra; Souquet, Pierre-Jean; Barlesi, Fabrice; Wislez, Marie.

Afiliación

Ruppert AM; GRC n°04, Theranoscan, AP-HP, Groupe Hospitalier Sorbonne Université, Hôpital Tenon, Paris, France.
Beau-Faller M; Department of Pneumology, AP-HP, Groupe Hospitalier Sorbonne Université, Hôpital Tenon, Paris, France.
Debieuvre D; Laboratory of Biochemistry and Molecular Biology, Centre Hospitalier Universitaire de Strasbourg, Hôpital de Hautepierre, Strasbourg, France.
Ouafik L; IRFAC UMR-S1113, Inserm, Université de Strasbourg, Strasbourg, France.
Westeel V; Department of Pneumology, GHRMSA, Emile Muller Hospital, Mulhouse, France.
Rouquette I; Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
Mazières J; Aix Marseille Univ, APHM, CHU Nord, Department of Tumor Biology, Marseille, France.
Bringuier PP; Centre Hospitalier Régional Universitaire de Besançon, Hôpital Jean Minjoz, Department of Pneumology, Besançon, France.
Monnet I; INSERM UMR 1098, Université de Bourgogne-Franche-Comté, Besançon, France.
Escande F; Pathology Department, Centre Hospitalier Universitaire de Toulouse Institut Universitaire du Cancer de Toulouse, Oncopôle, Toulouse, France.
Ricordel C; Department of Pneumology, CHU de Toulouse, Université Paul Sabatier, Toulouse, France.
Merlio JP; Institut de Pathologie Multisite des Hospices Civils de Lyon Site Est and Université Claude Bernard Lyon 1, Lyon, France.
Janicot H; Department of Pneumology, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Lemoine A; Laboratory of Biochemistry and Molecular Biology, CHRU Lille, Lille, France.
Foucher P; Unité COSS INSERM U1242 - CEM - Université de Rennes, Rennes, France.
Poudenx M; Department of Pneumology, CHU Rennes, Rennes, France.
Morin F; Department of Tumor Biology, CHU and University of Bordeaux, INSERM U1053, Bordeaux, France.
Langlais A; Department of Pneumology, CHU Clermont-Ferrand, Hôpital Gabriel Montpied, Clermont-Ferrand, France.
Souquet PJ; Department of Oncogenetics, AP-HP, Groupe Hospitalier APHP.Univeristé Pars-Saclay, Hôpital Paul Brousse, INSERM UMR-S 1193, Paris, France.
Barlesi F; Department of Thoracic Oncology, University hospital Dijon-Bourgogne, Dijon, France.
Wislez M; Departement of Oncology, MédicaleCentre Antoine Lacassagne, Nice, France.